the combined therapy of a gonadotrophin-releasing hormone agonist ( gnrha ) d-ser ( tbu ) 6-ea10-lhrh ( buserelin ) and human menopausal gonadotrophins ( hmg ) for ovarian stimulation for in-vitro fertilization and gamete intra-fallopian transfer was evaluated during 84 cycles .
C0023610
lhrh
C0006456
buserelin